Plasma Separation: How It Works and Why It’s Done

Plasma separation is the process of isolating the liquid portion of blood from its cellular components, and it underpins everything from routine blood tests to life-saving treatments for autoimmune diseases. Plasma itself is roughly 90–92% water, with the remaining fraction packed with proteins, electrolytes, hormones, and dissolved gases that make it one of the most diagnostically and therapeutically valuable substances in medicine.1PubMed. Physiology, Blood Plasma The techniques used to separate it range from a simple spin in a tabletop centrifuge to sophisticated membrane filters and, increasingly, miniaturized lab-on-a-chip devices small enough to fit in a handheld reader.

The Basic Idea Behind Separating Plasma

Whole blood is a mixture: red blood cells, white blood cells, and platelets are all suspended in plasma. Because these cells are denser than the liquid they float in, you can drive them apart by applying force. The most familiar method is centrifugation, where spinning blood in a tube pushes the heavier cells to the bottom and leaves the straw-colored plasma sitting on top. But force is not the only tool. Membranes with carefully sized pores can let plasma proteins and water pass through while physically blocking cells, much like a very fine coffee filter. And newer acoustic or microfluidic approaches use sound waves or the geometry of tiny channels to steer cells away from plasma without spinning anything at all.

Why bother? Because plasma and cells each carry different information, and mixing them together can obscure both. A lab measuring your cholesterol, hormone levels, or clotting factors needs plasma (or its close relative, serum) free of cellular debris. A patient whose immune system is attacking their own body may need harmful antibodies physically removed from their plasma. And the pharmaceutical industry needs pooled donor plasma broken down into purified proteins like albumin and immunoglobulins. Each of these goals demands separation, but the details differ.

Centrifugal Separation

Centrifugation remains the workhorse. In a clinical lab, a blood sample drawn into an anticoagulant-coated tube is loaded into a centrifuge and spun at several thousand revolutions per minute. The centrifugal force sorts particles by density: red blood cells pack tightly at the bottom, a thin “buffy coat” of white cells and platelets forms in the middle, and plasma rises to the top. The physics governing this process are well described using models of blood viscosity under centrifugal force.2PubMed. The physics of continuous flow centrifugal cell separation

For small diagnostic tubes, a fixed-angle or swing-bucket centrifuge does the job in about ten minutes. For larger-scale therapeutic procedures or blood banking, continuous-flow centrifuges process blood in a steady stream: blood enters one side, separation happens inside a spinning bowl or channel, and the desired component exits the other side while everything else is returned to the donor or patient. Some advanced designs incorporate a separator gel that sits at the interface between plasma and red cells after spinning, physically locking the layers apart and preventing remixing when the tube is handled.3PubMed Central. Extremely Precise Blood-Plasma Separation from Whole Blood on a Centrifugal Microfluidic Disk (Lab-on-a-Disk) Using Separator Gel

Membrane-Based Separation

The alternative to spinning blood is filtering it. Membrane plasma separation works a lot like kidney dialysis, and in fact it can be performed on a modified dialysis machine. The key difference is pore size: the membrane’s pores are large enough to let all dissolved molecules through, including large proteins and antibodies, while holding back cells.4PubMed Central. Therapeutic Plasma Exchange Using Membrane Plasma Separation Blood flows along one side of a hollow-fiber membrane, and pressure pushes plasma through to the other side. The cells, too large to fit through, continue along the fiber and are returned to the patient.

Membrane systems have some practical advantages in therapeutic settings. They do not require the large rotating hardware of a centrifuge, they can be compact enough for bedside use, and they avoid the mechanical shearing of cells that aggressive centrifugation can cause. The trade-off is that membranes can clog with proteins over time and are less selective than centrifuge-based systems when you need to isolate a specific cell type rather than simply separating plasma from everything else.

Continuous Flow Versus Intermittent Flow

When plasma separation is performed on a living person, as in a donation session or a therapeutic plasma exchange, the machine either draws blood continuously or in batches. Continuous-flow systems pull blood from one arm, process it in real time, and return the unwanted components to the other arm (or the same arm through a dual-lumen catheter). Intermittent-flow systems draw a batch of blood, process it in a chamber, return the cells, then draw another batch.

Head-to-head comparisons show practical differences. A study comparing the two approaches for therapeutic cell removal found that continuous-flow machines removed significantly less total volume from the patient during plateletapheresis, with fewer side effects and less hemoglobin loss.5PubMed. Therapeutic cytapheresis: continuous flow versus intermittent flow apheresis systems For stem cell collection, continuous-flow systems have been shown to extract roughly four times more of the target mononuclear cells per unit time than intermittent-flow devices.6Vox Sanguinis. Intrapatient Comparison of an Intermittent and a Continous Flow Cell Separator for the Collection of Progenitor and Stem Cells from the Blood That efficiency translates into shorter sessions for the person in the chair, which matters when you are attached to a machine for what can otherwise be several hours.

The Role of Anticoagulants

Blood starts clotting the moment it leaves the body. To separate plasma rather than serum, you need to stop that clotting process with an anticoagulant added to the collection tube or the machine circuit. The three most common options each work differently and affect downstream results in distinct ways.

The choice matters because each anticoagulant subtly alters the plasma’s composition. EDTA’s strong chelation strips out divalent metals that some enzymes need, making EDTA plasma a poor choice for assays that measure those enzyme activities. Heparin, by contrast, leaves mineral levels mostly intact but can interfere with certain molecular tests. For this reason, labs specify exactly which tube type to use for each test, and mixing them up is a common source of erroneous results.

Plasma Versus Serum in Diagnostic Testing

If you have ever had blood drawn, you may have noticed different colored caps on the tubes. Some contain anticoagulant and yield plasma; others do not, allowing the blood to clot before centrifugation. The liquid recovered after clotting is serum, which is plasma minus the clotting proteins (mainly fibrinogen). The distinction sounds minor, but it changes what a lab can measure.

Serum and plasma are not interchangeable. A proteomics study found that the concentrations of three-quarters of quantified metabolites differed between them, with amino acids in particular running higher in serum.9PubMed Central. Serum or Plasma (and Which Plasma), That Is the Question A broader metabolomics analysis identified 36 out of 72 compounds at significantly different levels between the two specimen types.10PubMed. Differences in metabolite profile between blood plasma and serum These differences arise because the clotting process itself releases substances from platelets and other cells, artificially raising certain analyte levels in serum. Different anticoagulants also produce measurably different plasma, adding another layer of variation.11PubMed. Sample management for clinical biochemistry assays: Are serum and plasma interchangeable specimens?

For the person getting a blood test, none of this requires action; the lab selects the right tube. But the takeaway is that plasma separation is not a generic one-size-fits-all step. The method and materials used to collect and process a sample shape what the results mean.

Therapeutic Plasma Exchange

Beyond diagnostics, plasma separation is a treatment in its own right. Therapeutic plasma exchange (TPE) removes a patient’s plasma and replaces it with a substitute fluid, effectively washing out harmful substances. The primary targets are autoantibodies, immune complexes, complement components, and inflammatory signaling molecules that drive tissue damage in autoimmune and other immune-mediated diseases.12PubMed. The role of plasma exchange in the management of autoimmune disorders By rapidly clearing these circulating molecules, TPE can interrupt the disease process fast enough to buy time for slower-acting immunosuppressive drugs to take effect.13PubMed. Mechanisms of immune modulation by therapeutic plasma exchange

A classic example is thrombotic thrombocytopenic purpura (TTP), a rare but dangerous blood disorder. In acquired TTP, autoantibodies attack an enzyme called ADAMTS13 that normally prevents excessive blood clotting in small vessels. Plasma exchange does double duty: it removes the destructive autoantibodies and replaces the missing enzyme by infusing fresh frozen plasma (FFP).14PubMed. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan Without timely exchange, TTP has a very high mortality rate.

Replacement Fluids

What goes back in after the harmful plasma comes out matters a great deal. In most situations, a 4–5% albumin solution in saline is preferred. Albumin solutions are heat-treated to kill viruses, rarely cause allergic reactions, and are easy to store.15PubMed. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange The downside is that albumin replaces only one protein; everything else, including clotting factors, immunoglobulins, and complement, gets diluted out. This creates a temporary deficiency that usually corrects itself within days as the body regenerates those proteins.

Fresh frozen plasma is the alternative when the patient needs those clotting factors replaced immediately, such as in TTP or when there is a pre-existing bleeding disorder. FFP carries a higher risk of allergic and transfusion reactions and must be blood-type matched, but it restores the full spectrum of plasma constituents. In procedures like selective plasma exchange for kidney transplantation across blood-type barriers, partial substitution with FFP has been used specifically to maintain clotting factor levels and reduce surgical bleeding risk.16Scientific Reports. Selective plasma exchange in ABO-incompatible kidney transplantation: comparison of substitution with albumin and partial substitution with fresh frozen plasma

Side Effects

The most common complication of therapeutic plasma exchange and platelet apheresis is a drop in blood calcium caused by the citrate anticoagulant. Citrate binds the calcium in your blood, and when citrate-containing blood is returned to you, your ionized calcium level can fall enough to cause tingling around the lips, numbness in the fingers, or muscle twitching.17PubMed. A liquid calcium+vitamin D(3) supplement is effective prophylaxis against hypocalcemic toxicity during apheresis platelet donation These symptoms are usually mild and manageable with oral or intravenous calcium supplements. More severe citrate toxicity, including muscle spasms and cardiac rhythm changes, is uncommon but possible, particularly in people with impaired kidney function who clear citrate more slowly.8PubMed Central. Anticoagulation techniques in apheresis: from heparin to citrate and beyond

Industrial Plasma Fractionation

Hospitals and pharmacies stock a range of products derived from donated human plasma: albumin for burn patients and people with liver failure, immunoglobulin concentrates for immune deficiencies, and clotting factors VIII and IX for hemophilia. Producing these requires separating plasma on a massive industrial scale and then breaking it down further into purified protein fractions.

The foundational technique, developed in the 1940s, uses cold ethanol to precipitate proteins out of plasma step by step, with each round of ethanol concentration, pH adjustment, and temperature change pulling a different protein group out of solution. Modern facilities have layered chromatographic purification on top of this process because it achieves higher purity.18PubMed Central. Implementation of Plasma Fractionation in Biological Medicines Production The four principal products, albumin, immunoglobulin G, factor VIII, and factor IX, serve millions of patients globally each year and cannot be synthesized artificially in sufficient quantities, making donated plasma an irreplaceable raw material.

Pathogen Safety in Plasma Products

Because plasma comes from human donors, the risk of transmitting blood-borne infections has always been a concern. Pathogen-reduction technologies applied during fractionation have been remarkably successful: there has been no confirmed transmission of HIV, hepatitis C, or hepatitis B from US-licensed plasma derivatives since 1987.19PubMed Central. Pathogen-reduction methods: advantages and limits

For fresh frozen plasma used in transfusion rather than fractionation, several photochemical treatments are now available that inactivate viruses, bacteria, and parasites directly in the plasma unit. A comparison of three such technologies found that each came with trade-offs: one minimized processing time and volume loss (about 1%), another retained the highest levels of clotting factors, and a third preserved factor V and XI best.20PubMed. Quantitative analysis of plasma proteins in whole blood-derived fresh frozen plasma prepared with three pathogen reduction technologies No single system dominates on every metric, so blood services weigh the priorities for their patient population.

How Storage Affects Plasma Quality

Once plasma is separated, the clock starts ticking on its biological activity. Most clotting factors hold up well at room temperature for several hours and remain stable when frozen, but factor VIII is the notable exception. At room temperature, factor VIII activity drops meaningfully within two hours; refrigeration slows the decline but does not stop it, and even frozen storage at standard temperatures (around −15 to −25 °C) shows a greater than 15% decline in factor VIII activity after about two months.21Scientific Reports. Effects of storage time and temperature on coagulation factor and natural anticoagulant activities in healthy individuals Factor V is also moderately labile under frozen storage, losing meaningful activity after roughly a month at the same temperature range.

This sensitivity is why blood banks freeze plasma as quickly as possible after separation and why FFP is defined by how soon after collection it was frozen. For patients with bleeding disorders who specifically need factor VIII, cryoprecipitate (a concentrated fraction of FFP) or recombinant factor VIII products offer more reliable potency than standard FFP that may have been stored for weeks.

Miniaturized and Point-of-Care Separation

Traditional plasma separation requires a centrifuge, trained personnel, and a properly equipped lab. That is fine in a hospital, but it creates a bottleneck in remote clinics, disaster zones, or anywhere a patient needs a fast answer from a drop of blood. Microfluidic devices aim to close that gap. These chip-scale systems use tiny channels, sometimes combined with filtration membranes or geometric features that exploit differences in cell size and stiffness, to separate plasma from a finger-stick sample in minutes without any external power source.22PubMed Central. Emerging Microfluidic Plasma Separation Technologies for Point-of-Care Diagnostics: Moving Beyond Conventional Centrifugation

Some of these devices integrate separation with downstream sensing. One passive microfluidic cartridge, designed for handheld use, has been demonstrated to separate blood and detect C-reactive protein (a marker of inflammation) at clinically relevant levels without any mechanical parts.23npj Biosensing. A passive blood separation sensing platform for point-of-care devices Another emerging approach uses acoustic waves to push cells to one side of a channel while plasma flows out the other. An acoustofluidic device has shown the ability to remove not just the larger red and white blood cells but also platelets, which are small enough to resist conventional microfluidic separation, by exploiting differences in acoustic impedance between blood and a sheath fluid.24Microsystems & Nanoengineering. An acoustofluidic device for the automated separation of platelet-reduced plasma from whole blood

These technologies are still largely in the research and early commercialization stage, but the trajectory is clear: moving plasma separation closer to the patient, faster, and cheaper.

Plasma Exchange in Veterinary Medicine

Therapeutic plasma exchange is not limited to humans. Dogs with severe immune-mediated blood disorders, conditions where the animal’s immune system destroys its own red blood cells or platelets, can be treated with membrane-based TPE using the same principles as in human patients. A retrospective study of dogs that had failed to respond to standard immunosuppressive drugs found that adding TPE produced outcomes at least as good as immunosuppression alone.25Journal of Veterinary Internal Medicine. Evaluation of membrane-based therapeutic plasma exchange as adjunctive treatment for immune-mediated hematologic disorders in dogs

Citrate toxicity, the same calcium-related side effect seen in humans, also occurs in dogs undergoing TPE. Veterinary researchers have worked out suggested citrate administration rates to keep the risk of severe citrate accumulation below about 20%, with lower rates recommended for dogs that have kidney problems and clear citrate more slowly.26Journal of Veterinary Internal Medicine. Membrane-based therapeutic plasma exchange in dogs: Prescription anticoagulation and metabolic response The parallels to human medicine are striking, and advances in one field tend to inform the other.